ACCESSWIRE

United States

Tel: 1-888-952-4446

About ACCESSWIRE

ACCESSWIRE is a global newswire and communications network, delivering regional, national and international news to thousands of customers across the world. ACCESSWIRE serves both public and private companies, disseminating their full-text and rich media press releases to news media, financial markets, investors, information websites, databases, bloggers and social networks.

The press release platform offers an exceptionally cost-effective Fair Disclosure, Regulation FD news dissemination and media outreach service.

Platform users can easily publish rich media assets, such as video, audio and images, and build their own distribution to the most-needed outlets. Users can effectively distribute an earnings announcement, product launch, community message, M&A transaction or corporate update to the worldwide news network.

Corporate issuers and their constituents find the cloud-based platforms and related services particularly robust — from document creation through dissemination to regulatory bodies, platforms and shareholders.

Contact ACCESSWIRE’s parent company, Issuer Direct, to learn more.

3460 articles with ACCESSWIRE

Hancock Jaffe Engages Syntactx for VenoValve U.S. Pivotal Trial

10/8/2020

Hancock Jaffe Laboratories, Inc. today announced that it has engaged Syntactx LLC to assist Hancock Jaffe with the VenoValve U.S. pivotal trial.
Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020

10/8/2020

Achieve Life Sciences, Inc. announced that it has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually October 13th - 16th, 2020.
Joining Forces Against SARS-COV-2: Rentschler Biopharma Contributes to Manufacturing of COVID-19 mRNA Vaccine

10/8/2020

Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2
Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer

10/8/2020

RELIEF THERAPEUTICS Holding AG today announced the appointment of Jack Weinstein as Chief Financial Officer (CFO) and Treasurer, effective immediately.
Halberd Corporation CEO Update Letter - October, 2020

10/8/2020

This initial CEO Letter reflects a summary of major accomplishments since I began my tenure at Halberd Corporation.
Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

10/7/2020

Initial Tranche of Non-dilutive Financing Transaction Increased from $5 Million to $6 Million by Mutual Consent with Lender, Providing Additional Q4 2020 Funding for Pivotal Phase 3 Clinical Trial and a Total Potential of $17 Million
Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator

10/7/2020

Heat Biologics, Inc. announced it has been issued a new US patent covering compositions of matter that are part of Heat's gp96 platform in combination with Inducible T cell Co-stimulator ligand or ICOSL, a T cell immune booster, in a single therapy.
ABMC to Distribute Co-Diagnostics Inc. EUA Issued Logix Smart(TM) Covid-19 Test

10/7/2020

American Bio Medica Corporation announced they have signed a distribution agreement with Co-Diagnostics, Inc. granting ABMC the right to market and sell the Logix Smart Covid-19 tests in the United States on a non-exclusive basis.
Nascent Biotech Announces Key Personnel Additions in Preparation for Coming Phase One Clinical Studies

10/7/2020

Nascent Biotech, Inc. announces that the Company is in the process of making significant additions to its core team in order to prepare for the initiation of key Phase One clinical trials to study the safety and efficacy of the Company's flagship drug, Pritumumab, a monoclonal antibody, for the treatment of Brain Cancer.
Intuitive Health and Riverview Health to Open West Carmel/Zionsville ER & Urgent Care Oct. 19

10/7/2020

Riverview Health Emergency Room & Urgent Care will open its third combined, freestanding emergency room and urgent care facility in Hamilton County in West Carmel/Zionsville on Monday, Oct. 19 at 7 a.m.
AllStar Health Brands Inc., (ALST) Announces Negotiations for Several QuikLAB Covid-19 Mobile Testing Units

10/7/2020

AllStar Health Brands Inc., a specialty pharmaceutical and nutritional supplements company, is pleased to announce advanced negotiations in Florida for up to three QuikLAB mobile testing units.
GT Biopharma Announces Expanded TriKE(TM) Partnership With Cytovance Biologics

10/6/2020

GT Biopharma, Inc. (OTCQB:GTBP) announced today that it had entered into a partnership agreement with Cytovance Biologics, a USA-based contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink").
Jaguar Health Meets Financial Condition for Sale of Royalty Rights for Mytesi (Crofelemer) Indications

10/6/2020

Financial Condition for Initial $5 Million Tranche of Potential $16 Million Non-dilutive Financing Transaction Achieved through the Establishment of an At-the-Market Program Yesterday for Potential Future Financing Needs, if Any, with Ladenburg Thalmann
Empower Clinics Acquires Medical Laboratory Capable of Processing 4,000 COVID-19 RT-PCR Tests Per Day

10/6/2020

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX, will advance Empower COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses, colleges and universities
Molecular Partners Demonstrates Reduction of Mortality and Potent Therapeutic Activity of Anti-COVID-19 DARPin(R) Candidates in Advanced COVID-19 Disease Model

10/6/2020

Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced supportive preclinical data from in vivo assessments of its DARPin® candidates targeting SARS-CoV-2.
Hemogenyx Pharmaceuticals PLC Announces SAFE-HEMO-CAR-T Effective against AML in vitro

10/6/2020

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce the following update on its activities.
GB Sciences Files Provisional Patent Application for the Treatment of Chronic Inflammation Utilizing Its Novel Cannabinoid Containing Complex Mixtures (CCCM)

10/6/2020

GB Sciences, Inc., has filed a provisional patent application, assigned to GBS Global Biopharma, Inc., for the use of its new proprietary cannabinoid containing complex mixtures for the treatment of chronic inflammation.
Hepion Pharmaceuticals Introduces Proprietary A.I. Platform for Drug Development & Announces Creation of Clinical Pharmacology Analytics Team

10/5/2020

Hepion Pharmaceuticals, Inc. today announced the rollout of a proprietary artificial intelligence ("AI"), machine learning platform called, AI-POWR™.
Aytu BioScience to Report Fourth Quarter and Full Year Fiscal 2020 Results and Provide Business Update on Tuesday, October 6, 2020

10/5/2020

Aytu BioScience, Inc. (NASDAQ:AYTU) announced today that the Company will present its operational results for the fiscal fourth quarter and year ended June 30, 2020 on October 6, 2020, at 4:30 p.m. ET.
Perimeter Medical Imaging AI Announces Further Update Regarding Second Quarter Financial Statements

10/1/2020

Perimeter Medical Imaging AI, Inc. is providing, as required by section 11 of BC Instrument 51-517 - Temporary Exemption from Certain Corporate Finance Requirements, a 30-day update on its previously-announced 45-day extension of the filing of its interim financial statements for its second quarter ending June 30, 2020.